📄Overview
Bureau of Pharma PSUs of India (BPPI) has invited limited tender bids for "Limited e-Tender to supply Drug Code- 1348 (Methylprednisolone Tablets IP 4mg) to PMBI through e-Tender no. PMBI/DRUG/LTD.-232/2026" at New Delhi, Delhi — a Unclassified works on a Item Rate basis, carrying an estimated value of ₹50.00 L. Bids close on 25 June 2026. EMD is ₹1.00 L. Reference PMBI/DRUG/LTD.-232/2026.
🗓️Timeline
Published
17 Jun 2026
Submission opens
18 Jun 2026
Submission closes
25 Jun 2026
Bid opening
29 Jun 2026
📎Tender documents
PDFTendernotice_1.pdfNIT · 266 KBPDFLimitedTender232.pdfTender document to supply Drug Code- 1348 (Methylprednisolone Tablets IP 4mg) to PMBI. · 1.1 MBXLSBOQ_960036.xlsBOQ to supply Drug Code- 1348 (Methylprednisolone Tablets IP 4mg) to PMBI. · 356 KB
Documents are mirrored from the source portal for reference. Live bidding and authoritative documents remain on the official portal.
📋Complete tender details
🏷️ Identification
Tender ID2026_BPPI_913483_1
Reference No.PMBI/DRUG/LTD.-232/2026
OrganisationBureau of Pharma PSUs of India (BPPI) » Head Office(Gurgaon) - BPPI
Product categoryDrugs and Pharmaceutical Products
💰 Commercials
Estimated value₹50.00 L
Form of contractItem Rate
EMD₹1,00,000
Tender feeNil
Payment modeOffline
⚖️ Process & eligibility
Tender typeLimited Tender
CategoryWorks
No. of covers2
Bid validity60 days
Two-stage biddingNo
Withdrawal allowedYes
📍 Location & authority
LocationNew Delhi, Delhi
PIN110029
Bid opening placeAs per tender document
Inviting authorityAs per tender document
❓Frequently asked questions
What is this tender for?
Bureau of Pharma PSUs of India (BPPI) floated this tender for "Limited e-Tender to supply Drug Code- 1348 (Methylprednisolone Tablets IP 4mg) to PMBI through e-Tender no. PMBI/DRUG/LTD.-232/2026" — Unclassified work, procured as a works contract on a Item Rate basis.
What is the estimated value?
The estimated value is ₹50.00 L.
What are the EMD and tender fee?
EMD is ₹1.00 L; tender fee is nil.
When do bids close?
Bids close on 25 June 2026; bids open on 29 June 2026.